Evidence map›Paper›PMID 42819561›Full record

ArticleCancer communications (London, England)2026

Frequent Novel Viral Focal Copy Number Gains Potentiate Radiosensitivity in Natural Killer/T-Cell Lymphoma.

Jing Quan Lim, The Phyu, Dachuan Huang, Beng Hooi Phang, Ziyu Fang, Kelila Chai Xin Ye, Nur Ayuni Binte Muhammad Taib, Wei Yi Ng, June Xin Ni Wong, Wendy Lee and 26 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer communications (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Jing Quan LimLymphoma Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.ORCID https://orcid.org/0000-0003-3732-8707
The PhyuDepartment of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Dachuan HuangLymphoma Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.
Beng Hooi PhangLymphoma Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.
Ziyu FangDepartment of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Kelila Chai Xin YeLymphoma Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.
Nur Ayuni Binte Muhammad TaibLymphoma Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.
Wei Yi NgLymphoma Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.
June Xin Ni WongDepartment of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Wendy LeeSingapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.
Kerry May Lim HuifenLymphoma Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.
Liang Wei WangSingapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.
Rou-Jun PengDepartment of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China.
Yi XiaDepartment of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China.
Yi-Qi LiDepartment of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China.
Anand JeyasekharanDepartment of Haematology-Oncology, National University Health System, Singapore, Singapore.
Soo Yong TanDepartment of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Chee Leong ChengDepartment of Pathology, Singapore General Hospital, Singapore, Singapore.
Nagavalli SomasundaramDivision of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Shin Yeu OngDepartment of Pathology, Singapore General Hospital, Singapore, Singapore.
Wee-Joo ChngCancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
Bernett LeeCentre for Biomedical Informatics, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Sai Mun LeongDepartment of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Olaf RötzschkeSingapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.
Lee-Yung ShihDivision of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan, China.
Jing TanDepartment of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China.
Jason Yongsheng ChanDepartment of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore.
Jie XiongShanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
Wei-Li ZhaoShanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
Fei YaoGenome Institute of Singapore, Agency for Science, Technology and Research, Singapore, Singapore.
Jianjun LiuGenome Institute of Singapore, Agency for Science, Technology and Research, Singapore, Singapore.
Soon Thye LimDirector's Office, National Cancer Centre Singapore, Singapore, Singapore.
Jin-Xin BeiDepartment of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China.
Chit Fang CheokDepartment of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Siok-Bian NgDepartment of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Choon Kiat OngLymphoma Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42819561
PMCPMC13624365

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.